Thyroid and Adrenal Disorders


Key Concepts

Hyperthyroidism

  • Hyperthyroidism induces a hypermetabolic state and increases β-adrenergic activity. The resulting clinical manifestations range from vague constitutional symptoms to more organ-specific symptoms (see Box 117.1 ).

    BOX 117.1
    Symptoms of Thyrotoxicosis

    • Constitutional: Weight loss despite hyperphagia, fatigue, generalized weakness

    • Hypermetabolic: Heat intolerance, cold preference, excessive perspiration

    • Cardiorespiratory: Palpitations, dyspnea, dyspnea on exertion, chest pains, poor exercise tolerance

    • Gastrointestinal: Nausea, vomiting, diarrhea, dysphagia

    • Neuropsychiatric: Anxiety, restlessness, hyperkinesis, emotional lability, confusion, insomnia, poor attention

    • Neuromuscular: Myopathy, myalgias, tremor, proximal muscle weakness (difficulty getting out of a chair or combing hair)

    • Ophthalmologic: Tearing, irritation, wind sensitivity, diplopia, foreign body sensation

    • Thyroid gland: Neck fullness, dysphagia, dysphonia

    • Dermatologic: Flushed feeling, hair loss, pretibial swelling

    • Reproductive: Oligomenorrhea, amenorrhea, menometrorrhagia, decreased libido, gynecomastia, erectile dysfunction, infertility

  • Hyperthyroidism in elders may be asymptomatic or may manifest with subtle nonspecific symptoms such as weight loss, shortness of breath, and/or dementia.

  • The laboratory test of choice for suspected hyperthyroidism is the thyroid stimulating hormone (TSH) concentration with free T 4 and T 3 levels.

  • Thyroid storm is a life-threatening thyrotoxic crisis that often presents with fever, extreme tachycardia, and/or altered sensorium. It requires prompt recognition and therapy, as well as identification and treatment of any precipitating cause, such as infection.

  • The order of medication administration in thyroid storm is critical. Iodine can precipitate thyroid storm and must be given a minimum of 1 hour after thionamide therapy (PTU or methimazole). As such, the typical order is beta blocker (propranolol), PTU or methimazole, and then iodine (SSKI, Lugol solution).

Hypothyroidism

  • Hypothyroidism results from lack of stimulation of the thyroid gland (central or secondary hypothyroidism) or intrinsic gland dysfunction limiting hormone production (primary hypothyroidism).

  • Signs and symptoms of hypothyroidism range from asymptomatic to overt organ failure, which can lead to death (see Box 117.5 ).

    BOX 117.5
    Symptoms and Signs of Hypothyroidism

    Vital Signs

    • Systolic blood pressure, normal or low

    • Diastolic blood pressure, normal or elevated

    • Slow pulse to sinus bradycardia

    • Respirations, normal or slow, shallow

    • Temperature, normal, but prone to hypothermia with stress

    Hypometabolic Complaints

    • Cold intolerance

    • Fatigue

    • Weight gain, but decreased appetite

    Cutaneous

    • Coarse, brittle hair

    • Alopecia

    • Dry skin, decreased perspiration

    • Pallor, cool hands and feet

    • Coarse, rough skin

    • Yellow tinge from carotenemia

    • Thin, brittle nails

    • Lateral thinning of the eyebrows

    Neurologic

    • Slow mentation and speech

    • Impaired concentrating ability and attention span

    • Lethargy

    • Decreased short-term memory

    • Agitation, psychosis

    • Seizures

    • Ataxia, dysmetria

    • Mononeuropathy

      • Carpal tunnel syndrome

      • Sensorineural hearing loss

    • Peripheral neuropathy, paresthesias

    Muscular

    • Proximal myopathy

    • Pseudohypertrophy

    • Delayed relaxation of reflexes (hung up or pseudomyotonic)

    Cardiac

    • Decreased exercise capacity

    • Dyspnea on exertion

    • Sinus bradycardia

    • Long QT with increased ventricular arrhythmia

    • Chest pain, accelerated coronary disease

    • Diastolic heart failure (delayed ventricular relaxation)

    • Pericardial effusion (asymptomatic)

    • Peripheral edema

    Respiratory

    • Dyspnea on exertion

    • Obstructive sleep apnea

    • Primary pulmonary hypertension

    Gastrointestinal

    • Constipation

    • Ileus

    • Gastric atrophy

    Reproductive

    • Oligomenorrhea and amenorrhea

    • Menorrhagia

    • Decreased fertility

    • Early abortions

    • Decreased libido

    • Erectile dysfunction

    Rheumatic

    • Polyarthralgias

    • Joint effusions

    • Acute gout or pseudogout

    Head, Ear, Eyes, Nose, and Throat

    • Hoarseness

    • Deep husky voice

    • Macroglossia

    • Hearing loss

    • Periorbital swelling

    • Broad nose

    • Swollen lips

    • Goiter

  • Determination of an elevated TSH level is the most sensitive and single best screening test to confirm the diagnosis of primary hypothyroidism.

  • Replacement with levothyroxine (T 4 ) remains the treatment of choice and resolves physical and psychological signs and symptoms in most patients.

  • Myxedema coma is a life-threatening event that presents with altered mental status and hypothermia, along with a concomitant precipitating event (see Box 117.6 ). It usually occurs in patients with untreated or undertreated hypothyroidism. Treatment with thyroid hormone replacement must be initiated, often based solely on clinical findings.

    BOX 117.6
    Myxedema Coma: Aggravating or Precipitating Factors
    T 3 , Triiodothyronine; T 4 , thyroxine.

    • Infection, sepsis (especially pneumonia)

    • Exposure to cold

    • Cerebrovascular accident

    • Drug effect

      • Altered sensorium: sedative-hypnotics, narcotics, anesthesia, neuroleptics

      • Decreased T 4 and T 3 release: amiodarone, lithium, iodides

      • Enhanced elimination of T 4 and T 3 : phenytoin, rifampin

      • Inadequate thyroid hormone replacement: noncompliance; interference with absorption (iron, calcium, cholestyramine)

    • Myocardial infarction

    • Gastrointestinal bleeding

    • Trauma, burns

    • Congestive heart failure

    • Hypoxia

    • Hypercapnia

    • Hyponatremia

    • Hypoglycemia

    • Hypercalcemia

    • Diabetic ketoacidosis

Adrenal Excess States

  • Adrenal excess states run the spectrum from Cushing syndrome, to primary and secondary hyperadrenalism, to pheochromocytoma.

  • Symptoms of adrenal excess will vary, depending on the etiology, with chronic, nonspecific symptoms that arise from Cushing syndrome (generalized weakness, fatigue, menstrual irregularities, and weight gain), to simple refractory hypertension with hyperaldosteronism, to acute, refractory hypertension and hyperadrenergic symptoms with pheochromocytoma.

  • Diagnosis of hyperaldosteronism is typically clinical, and confirmed by laboratory testing and imaging studies, depending on the etiology. In most cases, acute stabilization of the presenting complaint is paramount, and definitive diagnosis will occur outside the ED. Any adrenal incidentaloma discovered on imaging obtained in the ED, especially in the setting of hypertension, should prompt further evaluation for adrenal excess.

Adrenal Insufficiency

  • Clinical manifestations of secondary adrenal insufficiency are often vague and nonspecific, including fatigue, weakness, dizziness, nausea, vomiting, and other nonspecific GI symptoms. Patients with primary adrenal insufficiency characteristically have more pronounced clinical manifestations and skin hyperpigmentation.

  • The ACTH stimulation test and measurements of cortisol levels is the most convenient method and is considered the criterion standard to make the diagnosis.

  • Refractory hypotension in the acutely ill patient may be the only clue to adrenal insufficiency and is readily treated with IV administration of glucocorticoids (hydrocortisone, 100 mg).

Hyperthyroidism

Foundations

Background and Importance

Hyperthyroidism is a condition caused by overproduction and increased circulation of thyroid hormone. The disorder runs the spectrum from subclinical hyperthyroidism to thyrotoxicosis and thyroid storm, a life-threatening disorder. Thyrotoxicosis is a hypermetabolic condition that results from elevated levels of thyroid hormones—triiodothyronine (T 3 ) and thyroxine (T 4 ). This can occur from hormone overproduction, increased thyroid hormone release from an injured gland, or exogenous thyroid hormone. For the purpose of this discussion, the terms hyperthyroidism and thyrotoxicosis are used interchangeably.

Anatomy, Physiology, and Pathophysiology

The normal adult thyroid gland is a highly vascular bilobar organ overlying the anterior trachea ( Fig. 117.1 ). The thyroid’s function is to secrete two iodinated hormones, T 3 and T 4 . Only about 20% of circulating T 3 is directly secreted by the thyroid; the remainder is produced by peripheral conversion of T 4 to the more biologically active T 3 . The thyroid is the only endocrine gland that stores large quantities of hormone.

Fig. 117.1, Anatomy of the thyroid gland and related structures.

Hormone production is regulated by a negative feedback loop involving the hypothalamic-pituitary-thyroid axis ( Fig. 117.2 ). As the serum levels of T 4 and T 3 fall, the hypothalamus releases the tripeptide thyrotropin-releasing hormone (TRH), which in turn stimulates the anterior pituitary gland’s release of the polypeptide thyroid-stimulating hormone (TSH) from its thyrotroph cells. TSH then binds to epithelial cells on the thyroid gland, stimulating follicular cells to synthesize and secrete the thyroid hormones T 4 and T 3 . TRH release may also result from exercise, stress, malnutrition, hypoglycemia, and sleep.

Fig. 117.2, Negative feedback loop of thyroid hormone regulation—hypothalamic-pituitary-thyroid axis. Thyroid hormone production is regulated by the hypothalamus and pituitary gland. Hypothalamic thyrotropin-releasing hormone (TRH) stimulates pituitary thyrotropin (TSH) synthesis and secretion. In turn, TSH stimulates the production and release of thyroxine (T 4 ) triiodothyronine (T 3 ) from the thyroid gland. Once released, T 4 and T 3 exert a negative feedback mechanism on the production of TRH and TSH. T 4 is converted to T 3 in the peripheral tissues.

The function of thyroid hormone is to influence the metabolism of cells by increasing their basal metabolic rate. It has a role in protein synthesis and functions together with other hormones necessary for normal growth and development. T 3 and T 4 increase the expression and sensitivity of β-adrenergic receptors, increasing the response to endogenous catecholamines.

T 4 is a prohormone with only mild intrinsic activity; its deiodination produces T 3 , the biologically active hormone. More than 99.5% of thyroid hormones are protein-bound in the serum to thyroxine-binding globulin (TBG) and other proteins, rendering them metabolically inactive. As a result, only free T 4 and free T 3 are clinically relevant.

Although iodide is a necessary substrate for thyroid hormone production, excess iodide can have two opposing effects. In the Wolff-Chaikoff effect, excess iodine inhibits the release of thyroid hormone from the gland by blocking iodide trapping and thyroglobulin iodination. This inhibition is transient, typically lasting only a matter of days. An iodine load can induce hyperthyroidism (Jod-Basedow effect) in some patients with multinodular goiter and occult Graves disease.

Clinical Features

History and Physical Examination

Hyperthyroidism induces a hypermetabolic state and increases β-adrenergic activity. The resulting clinical manifestations range from vague constitutional symptoms to more organ-specific symptoms ( Box 117.1 ). Altered mental status and coma typify thyroid storm, the most severe manifestation of disease.

Hyperthyroidism in older adults often manifests in more subtle ways, often asymptomatic or with nonspecific symptoms of weight loss, shortness of breath, and/or dementia. Elders are more prone to cardiac manifestations of hyperthyroidism and may present with atrial fibrillation. Elders who smoke or have higher circulating thyroid hormone levels appear to have more severe symptoms. Thyrotoxic periodic paralysis is a rare manifestation that presents as a sudden and profound muscle weakness progressing to flaccid paralysis, similar to familial hypokalemic periodic paralysis.

Ophthalmopathy is a classic finding in Graves disease. Patients subsequently present with eyelid edema, hyperemia, conjunctival hyperemia, and chemosis. Graves ophthalmopathy is also associated with restrictive extraocular myopathy, and exophthalmos. As the disease progresses, patients may experience restriction of their upward gaze from infiltration of the inferior rectus muscle and visual loss from optic nerve involvement (compression by inflamed, enlarged orbital contents). Increased activity at the sympathetic innervation of the eyelids leads to widening of the palpebral fissures, resulting in the characteristic stare and lid lag of thyrotoxicosis.

Physical examination findings of hyperthyroidism depend largely on age ( Box 117.2 ). Younger patients typically present with signs of sympathetic stimulation, whereas older adults often lack the same adrenergic response and present with weight loss and fatigue, more consistent with apathetic hyperthyroidism. In Graves disease, patients uncommonly have classic pretibial myxedema, which are confluent, painless, reddish raised nodules and plaques over the pretibial area and dorsum of the feet, often described as orange skin. Hyperpigmentation and induration are present, but pitting is absent. Pretibial myxedema is often associated with Graves ophthalmopathy.

BOX 117.2
Physical Findings in Thyrotoxicosis

  • Vital signs: Tachycardia, widened pulse pressure, bounding pulses, fever

  • Cardiac: Hyperdynamic precordium, systolic flow murmur, prominent heart sounds, systolic rub (Means-Lerman scratch), tricuspid regurgitation, atrial fibrillation, evidence of heart failure

  • Ophthalmologic: Widened palpebral fissures (stare), lid lag, globe lag, conjunctival injection, periorbital edema, proptosis, limitation of superior gaze

  • Neurologic: Fine tremor, hyperreflexia, proximal muscle weakness

  • Psychiatric: Fidgety, emotionally labile, poor concentration

  • Dermatologic: Warm, moist, smooth skin; rosy cheeks, blushing face; fine brittle hair; alopecia, flushed facies; palmar erythema; hyperpigmented pretibial plaques, nodules, or induration that is nonpitting; onycholysis (Plummer nails, separation of the distal portion of the fingernail from the nail bed)

  • Neck: Diffuse symmetric thyroid enlargement, sometimes with a bruit and palpable thrill; thyroid with multiple irregular nodules or a prominent single nodule; tracheal deviation, venous prominence with arm elevation (Pemberton sign)

Tachycardia is the most common cardiac finding. Other findings include a widened pulse pressure, bounding peripheral pulses and, rarely, a friction rub heard along the left sternal border (Means-Lerman scratch). Atrial fibrillation is more common in elders, especially those over 65 years of age. Dilated cardiomyopathy may develop as a complication of a high cardiac output state. Patients can also develop primary pulmonary hypertension, as well as increased chamber size and poor right ventricular function.

Most hyperthyroid patients have an enlarged thyroid gland, especially in toxic multinodular goiter or Graves disease, although many elders with Graves disease have nonpalpable thyroids. Retrosternal enlargement can occur, making detection difficult while causing the obstructive symptoms discussed earlier. Facial and neck vein engorgement can be elicited when arms are elevated above the head (known as the Pemberton sign). The absence of thyroid enlargement should suggest exogenous (factitious) thyroiditis as well as ectopic thyroid hormone production, such as a hydatidiform mole or struma ovarii, an ovarian tumor composed of some thyroid tissue.

Thyroid Storm

Thyroid storm is a rare, life-threatening form of severe thyrotoxicosis, with multiorgan dysfunction and significantly higher mortality rates than thyrotoxicosis without storm. Although it can occur as the result of unrecognized or undertreated thyrotoxicosis, more often, it is an acute reaction to surgery, trauma, infection, iodine load or parturition in patients with preexisting hyperthyroidism. Other precipitants include acute myocardial infarction, pulmonary embolism, hyperemesis gravidarum, preeclampsia, and diabetic ketoacidosis. Untreated, mortality approaches 100%, but prompt recognition and therapy have lowered mortality to 10% to 30%. , Death in thyroid storm is caused by multiorgan dysfunction, congestive heart failure, respiratory failure, arrhythmias, disseminated intravascular coagulation, hypoxic brain insult, or sepsis.

The typical clinical manifestations of thyroid storm include marked pyrexia (104°–106°F [40°–41°C]), extreme tachycardia (often out of proportion to level of fever), and altered mental status. These findings, coupled with the clinical picture of a patient with hyperthyroidism, lid lag, stare, goiter, ophthalmopathy, and tremor, should alert the emergency clinician to the diagnosis. Cardiovascular collapse can result in congestive heart failure, hypotension, and cardiac arrhythmias. Hypotension can also result from volume depletion secondary to nausea, vomiting, and diarrhea. Abdominal pain is common; hepatic failure with cholestatic jaundice is less common but carries a poor prognosis. Thyroid storm is a clinical diagnosis, and no validated diagnostic criteria yet exist. However, a scoring system developed by Burch and Wartofsky in 1993 is repeatedly cited and utilized by practicing endocrinologists. Although the test characteristics (e.g., sensitivity and specificity) have not been published, it may help distinguish among thyrotoxicosis, impending thyroid storm, and frank thyroid storm ( Table 117.1 ).

TABLE 117.1
Diagnostic Criteria for Thyroid Storm
Criteria Score a
Fever (°F)
99–99.9 5
100–100.9 10
101–101.9 15
102–102.9 20
103–103.9 25
≥104 30
Tachycardia (beats/min)
90–109 5
110–119 10
120–129 15
130–139 20
≥140 25
Mental Status
Normal 0
Mild agitation 10
    • Delirium, psychosis

Extreme lethargy 20
Coma, seizures 30
Congestive Heart Failure
Absent 0
Mild (edema) 5
Moderate (rales) 10
Pulmonary edema 15
Atrial fibrillation 10
Gastrointestinal and Hepatic Symptoms
None 0
Nausea, vomiting 10
    • Diarrhea, abdominal pain

Unexplained jaundice 20
Precipitating Event
None 0
Present 10

a Tally the maximum score from each category. A score of 45 or higher suggests thyroid storm, or impending storm, and a score below 25 is unlikely to represent thyroid storm.

Differential Diagnoses

The differential diagnosis for the thyrotoxic patient is broad. An anxious patient may be interpreted to be manic or experiencing a panic attack. The hyperadrenergic state may be confused with that seen in patients with sympathomimetic intoxication, suffering from anticholinergic crisis, or experiencing withdrawal from alcohol or sedative-hypnotics. The hyperpyrexia and altered mental status seen in thyroid storm may mimic other hyperthermic disorders such as heatstroke, neuroleptic malignant syndrome, serotonin syndrome, bacterial meningitis, and sepsis. Elders with apathetic hyperthyroidism may be mistakenly diagnosed with psychiatric illness.

Diagnostic Testing

The initial diagnosis of thyrotoxicosis is based on the clinical picture and confirmed with laboratory values. Measurement of the serum TSH level is the most sensitive test for hyperthyroidism. In thyrotoxicosis, the serum TSH concentration is depressed or undetectable (<0.01 μU/mL in third-generation assays), and a normal TSH level excludes hyperthyroidism. Accuracy of the TSH determination is improved when the free T 4 test is added. Assessment of thyroid function during acute nonthyroidal illness is difficult, especially in critically ill patients. Severe systemic illness depresses TSH production, leading to low levels of TSH, free T 3 , and free T 4 .

Elevation of free T 4 and free T 3 levels in conjunction with TSH suppression is diagnostic of thyrotoxicosis. Because nearly all T 3 and T 4 is bound to TBG, assays measuring total T 3 or T 4 are influenced by changes in TBG; they are therefore unreliable and should not be used. Subclinical hyperthyroidism is likely if TSH is suppressed and the free T 4 level is normal. T 3 toxicosis occurs in about 5% of patients with thyrotoxicosis. These patients have an elevated free T 3 level and a normal free T 4 level. When the reverse pattern is present—normal free T 3 level and elevated free T 4 level—the differential includes thyroiditis, exogenous levothyroxine ingestion, and hyperthyroidism in elders, often with suppressed T 4 to T 3 conversion due to comorbid illness ( Table 117.2 ). Since Graves is caused by autoantibodies to the TSH receptor, the presence of thyroid receptor antibodies in the serum can help distinguish it from other causes. Additionally, a radioiodine scan can help discern Graves from exogenous intake or hyperthyroidism due to struma ovarii. A magnetic resonance imaging (MRI) test of the brain and an ultrasound of the thyroid may help differentiate whether excess levels of thyroid hormone are emanating from either the pituitary or the thyroid gland.

TABLE 117.2
Thyroid Function Test Interpretation
Tsh Free T 4 Free T 3 Disease
Normal Normal Normal None
Low High High Hyperthyroidism
Low Normal Normal Subclinical hyperthyroidism
Low Normal High T 3 toxicosis
Low High Normal Thyroiditis, T 4 ingestion, hyperthyroidism in older adults or those with comorbid illness
Low Low Low Euthyroid sick syndrome; central hypothyroidism
High Normal Normal Subclinical hypothyroidism; recovery from euthyroid sick syndrome
T 3 , Triiodothyronine; T 4 , thyroxine; TSH, thyroid-stimulating hormone.

Many thyrotoxic patients have hyperglycemia. This is likely to be the result of increased glycogenolysis and catecholamine-mediated antagonism of insulin. Mild hypercalcemia can be seen, is related to hormone-mediated bone resorption, and is associated with osteoporosis and increased fracture risk. Other frequent laboratory abnormalities include abnormal liver function tests, leukocytosis, mild anemia, and low serum cholesterol levels.

In thyroiditis, the diagnostic evaluation is more difficult. An exquisitely tender gland and elevated erythrocyte sedimentation rate (ESR) or C-reactive protein make the diagnosis of subacute thyroiditis likely. The other forms of thyroiditis lack these findings.

Factitious thyrotoxicosis can often be diagnosed by history. Laboratory testing will demonstrate low thyroglobulin levels and a low T 3 /T 4 ratio (<20 ng/microgram). Furthermore, radioactive iodine uptake is depressed in thyroiditis and factitious thyrotoxicosis but increased in hyperthyroidism.

Management

Management of thyrotoxicosis is based on etiology and symptom severity. For those with mild symptoms, outpatient referral and management are appropriate. Patients with moderate to severe symptoms are best managed in the emergency department (ED) setting. Treatment is divided into supportive, symptomatic, and thyroid-directed therapy. Specific dosages of the drugs discussed in the following sections can be found in Box 117.3 . The order of medication administration in thyroid storm is critical. Iodine can precipitate thyroid storm and must be given a minimum of 1 hour after thionamide therapy (PTU or methimazole). As such, the typical order is beta blocker (propranolol), propylthiouracil (PTU), or methimazole, and then iodine (saturated solution of potassium iodide [SSKI], Lugol solution). In addition, it is important to identify and treat the precipitating cause of thyroid storm.

BOX 117.3
Management of Thyrotoxicosis
CHF, Congestive heart failure; D 5 W/0.9 NS, 5% dextrose in 0.9% normal saline; IV, intravenously; NG, by nasogastric tube; PO, by mouth; PR, by rectum; T 3 , triiodothyronine; T 4 , thyroxine.

β-Adrenergic Blockade

  • Propranolol 60–80 mg PO every 4 hours

  • or

  • Metoprolol, 25–50 mg PO every 6 hrs

  • If IV route is required, propranolol, 0.5–1.0 mg IV slow push test dose, then repeat 1–2 mg every 15 min as tolerated to desired effect, then 1–2 mg every 3 hr

  • or

  • Esmolol, 50–100 μg/kg/min infusion

  • Strict contraindication to beta blocker—reserpine 2.5–5 mg IM every 4 hr

Inhibition of Thyroid Hormone Synthesis

  • Propylthiouracil, 500–1000 mg loading dose, then 250 mg every 4 hr

  • or

  • Methimazole, 60–80 mg/day in divided doses

  • Preferred route, PO or nasogastric (NG); alternative route: PR (in rectum), enema prepared by pharmacy; same dose for all routes

Inhibition of Thyroid Hormone Release

  • Saturated solution of potassium iodide (SSKI, 50 mg iodide/drop), 1–2 drops PO or PR tid

  • or

  • Lugol solution (8 mg iodide/drop), 5–7 drops PO or PR tid

  • or

  • Sodium iodide, dosing as per Endocrinology recommendations

  • or

  • If allergic to iodine, lithium carbonate, 300 mg PO or NG qid

Administration of Corticosteroids

  • Inhibit T 4 to T 3 conversion; treat relative adrenal insufficiency.

  • Hydrocortisone, 300 mg IV, followed by 100 mg tid

  • or

  • Dexamethasone, 2–4 mg IV qid

Diagnosis and Treatment of Underlying Precipitant

  • Consider empirical antibiotics if critical.

Supportive Measures

  • Volume resuscitation and replacement of glycogen stores with D 5 /0.9 NS (dose varies, depending on volume status and CHF)

  • Acetaminophen

  • Cooling blanket, fans, ice packs, ice lavage

Miscellaneous

  • Lorazepam or diazepam as anxiolytic and to decrease central sympathetic outflow

  • Cholestyramine (blocks enterohepatic recirculation of thyroid hormone), 1–4 g PO twice daily for severe or refractory thyrotoxicosis

Supportive Treatment

Supportive therapy for thyroid storm patients should include management of hyperthermia with cooling and acetaminophen. Aspirin should be avoided in thyrotoxic patients because it decreases the protein binding of T 4 and T 3. Agitation is controlled with benzodiazepines. Fluid resuscitation is needed to compensate for insensible and gastrointestinal (GI) losses; dextrose-containing solutions are helpful because glycogen stores are often depleted. Electrolyte replacement is guided by laboratory values.

Symptomatic Treatment

Symptomatic treatment consists primarily of beta blockade to diminish the adrenergic response. Propranolol is the beta blocker of choice because it has the added benefit of blocking conversion of T 4 to T 3 ; its nonselective effects also improve tremor, weakness, hyperpyrexia, restlessness, irritability, and emotional lability. The onset of action after oral dosing is about 1 hour.

For more rapid beta blockade, propranolol can be administered intravenously (IV). A short-acting agent such as esmolol may be used when concerns about beta blockade exist, due to underlying asthma or COPD, or pulmonary edema from heart failure. In asthmatics, a β 1 -selective drug such as esmolol or metoprolol may be considered.

If beta blockers are contraindicated, reserpine, 2.5 to 5 mg intramuscularly (IM) every 4 hours, is also an option. Patients should be closely monitored for hypotension, regardless of the agent used, because thyrotoxicosis can lower systemic vascular resistance and cause congestive heart failure. Patients who develop clinically significant heart failure should be treated with the usual medications for heart failure, including diuretics and angiotensin-converting enzyme inhibitors. Atrial fibrillation is often refractory to rate control until antithyroid therapy is instituted.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here